LOW-MOLECULAR-WEIGHT HEPARINS AND TICLOPIDINE
Concurrent use of ticlopidine with a low-molecular-weight heparin increases haemorrhagic risk.
If concurrent use is undertaken, there should be close clinical and laboratory monitoring.
If concurrent use is undertaken, there should be close clinical and laboratory monitoring.